Viewing Study NCT04696393


Ignite Creation Date: 2025-12-25 @ 1:08 AM
Ignite Modification Date: 2025-12-27 @ 2:15 AM
Study NCT ID: NCT04696393
Status: COMPLETED
Last Update Posted: 2021-04-13
First Post: 2021-01-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Compare the Pharmacokinetics and Safety of Mitapivat 100 mg Tablet Formulation With Mitapivat 2 × 50 mg Tablet Formulation in Healthy Adult Participants
Sponsor: Agios Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module